US Giant Apollo Bags Billion-Euro Partnership with Sofinnova
As biotech investment slows following a record-breaking year, the Paris-based Sofinnova Partners has landed a…
May 17, 2022 - 3 minutes
Anita Chakraverty
Anita Chakraverty is a freelance medical journalist and science communicator. Outside work, she enjoys a good movie, long walks in the local woods, and trying to get into pretzel-like yoga poses.
Melt&Marble Gains €5M to Brew Fat Alternatives Using Engineered Yeast
Tapping into the increasingly sophisticated market for meat alternatives, the Swedish synthetic biology startup Melt&Marble…
May 6, 2022 - 4 minutes
WHO Beefs up Worldwide Genomic Surveillance to Prevent Pandemics
The World Health Organization has released a 10-year plan to monitor the genetic make-up of…
April 5, 2022 - 4 minutes
Precision Medicine Startups Increase Focus on Data Access and Privacy
Low-cost genetic sequencing is becoming increasingly accessible and profitable for companies, but data protection and…
March 31, 2022 - 4 minutes
Biotechs Carve out Niches in Cystic Fibrosis Treatment Space
Cystic fibrosis has proved resistant to treatments that provide long-lasting respite from the sticky mucus…
March 22, 2022 - 5 minutes
Argenx’s Potential Blockbuster Gets FDA Nod for Autoimmune Disease
US regulators have approved the first-in-class drug efgartigimod for the treatment of the rare muscle…
December 21, 2021 - 4 minutes
ATP Blazes US Venture Capital Trail into European Biotech Startups
The US venture capital firm Apple Tree Partners (ATP) is making its first transatlantic foray…
December 14, 2021 - 4 minutes
Targeted Drugs for Rare Autoimmune Disease Hit Regulatory Milestones
New, more targeted treatments are on the horizon for the rare autoimmune disease ANCA-associated vasculitis,…
December 1, 2021 - 4 minutes
Sustainability in Focus as Two VCs Build Industrial Biotech Funds
As this month’s COP26 United Nations climate summit highlighted the climate change emergency, venture capital…
November 18, 2021 - 4 minutes
Big Pharma Strikes Megadeals In Targeted Protein Degradation
With many targeted protein degraders hitting the clinic, lucrative collaborations and acquisitions are being signed…
November 12, 2021 - 5 minutes
Skilled Labor Shortages Impact Cell And Gene Therapy Manufacturing
Despite vast amounts of funding entering the cell and gene therapy field, the manufacture of…
November 4, 2021 - 5 minutes
Gene-Edited T Cell Therapy Players Battle Safety Doubts
Confidence in gene-edited T cell therapies from donor cells has faltered as Allogene Therapeutics paused…
October 22, 2021 - 5 minutes
